Canadian breast implant cohort: Extended follow-up of cancer incidence

International Journal of Cancer

Volumn 131, Issue 7, 2012, Pages

  Pan, Sai Yi ^a   Lavigne, Eric ^a,b   Holowaty, Eric J ^c   Villeneuve, Paul J ^c,d   Xie, Lin ^a   Morrison, Howard ^a   Brisson, Jacques ^b  

^a PUBLIC HEALTH AGENCY OF CANADA   (Canada)

^b LAVAL UNIVERSITY   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d HEALTH CANADA   (Canada)

Author keywords

breast implants; breast neoplasms; incidence; polyurethane

Indexed keywords

POLYURETHAN; SILICONE;

ADULT; ARTICLE; BREAST ENDOPROSTHESIS; CANADA; CANCER INCIDENCE; COHORT ANALYSIS; CONTROLLED STUDY; ENDOMETRIUM CANCER; ESTHETIC SURGERY; FEMALE; FOLLOW UP; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

ADOLESCENT; ADULT; BREAST IMPLANTS; BREAST NEOPLASMS; CANADA; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MIDDLE AGED; YOUNG ADULT;

EID: 84864443863     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.27603     Document Type: Article

References (50)

1. Mclaughlin JK, Lipworth L, Murphy DK, et al. The safety of silicone gel-filled breast implants. A review of the epidemiologic evidence. Ann Plast Surg 2007; 59: 569-80.
2. Deapen DM,. Breast implants and breast cancer: a review of incidence, detection, mortality, and survival. Plast Reconstr Surg 2007; 120 (Suppl 1): 70S-80S.
3. U.S.Food and Drug Administration Center for Devices and Radiological Health. FDA Update on the Safety of Silicone Gel-Filled Breast Implants, 2011.
4. Lilla JA, Vistnes LM,. Long-term study of reactions to various silicone breast implants in rabbits. Plast Reconstr Surg 1976; 57: 637-49.
5. Health Canada. Drugs and health products: notice of decision for silicone gel-filled breast implants. Health Canada, 2009. Available at.
6. Friis S, Holmich LR, Mclaughlin JK, et al. Cancer risk among Danish women with cosmetic breast implants. Int J Cancer 2006; 118: 998-1003.
7. Brisson J, Holowaty EJ, Villeneuve PJ, et al. Cancer incidence in a cohort of Ontario and Quebec women having bilateral breast augmentation. Int J Cancer 2005; 118: 2854-62.
8. Mellemkjaer L, Kjoller K, Friis S, et al. Cancer occurence after cosmetic breast implantation in Denmark. Int J Cancer 2000; 88: 301-6.
9. Deapen DM, Brody GS,. Augmentation mammaplasty and breast cancer: a 5-year update of the Los Angeles study. Plast Reconstr Surg 1992; 89: 660-5.
10. Deapen DM, Bernstein L, Brody GS,. Are breast implants anticarcinogenic? A 14-year follow-up of the Los Angeles study. Plast Reconstr Surg 1997; 99: 1346-53.
11. Cohney BC, Cohney TB, Hearne VA,. Augmentation mammaplasty-a further review of 20 years using the polyurethane-covered prosthesis. J Long Term Eff Med Implants 1992; 1: 269-79.
12. Expert Panel on the Safety of Polyurethane-covered Breast Implants. Safety of polyurethane-covered breast implants. CMAJ 1991; 145: 1125-32.
13. Lipworth L, Tarone RE, Friis S, et al. Cancer among scandinavian women with cosmetic breast implants: a pooled long-term follow-up study. Int J Cancer 2009; 124: 490-3.
14. Deapen DM, Hirsch EM, Brody GS,. Cancer risk among Los Angeles women with cosmetic breast implants. Plast Reconstr Surg 2007; 119: 1987-92.
15. Mclaughlin JK, Lipworth L, Fryzek JP, et al. Long-term cancer risk among Swedish women with cosmetic breast implants: an update of a nationwide study. J Natl Cancer Inst 2006; 98: 557-60.
16. Pukkala E, Boice JD, Jr, Hovi S-L, et al. Incidence of breast cancer and other cancers among Finnish women with cosmetic breast implants, 1970-1999. J Long Term Eff Med Implants 2002; 12: 251-3.
17. Brinton LA, Lubin J, Burich MC, et al. Breast cancer following augmentation mammoplasty (United States). Cancer Causes Control 2000; 11: 819-27.
18. Brinton LA,. The relationship of silicone breast implants and cancer at other sites. Plast Reconstr Surg 2007; 120 (Suppl 1): 94S-102S.
19. Mclaughlin JK, Nyren O, Blot WJ, et al. Cancer risk among women with cosmetic breast implants: a population based cohort study in Sweden. J Natl Cancer Inst 1998; 90: 156-8.
20. Lipworth L, Tarone RE, Mclaughlin JK,. Breast implants and lymphoma risk: a review of the epidemiologic evidence through 2008. Plast Reconstr Surg 2009; 123: 790-3.
21. Jewell M, Spear SL, Largent J, et al. Anaplastic large T-cell lymphoma and breast implants: a review of the literature. Plast Reconstr Surg 2011; 128: 651-61.
22. U.S.Food and Drug Administration. Anaplastic large cell lymphoma (ALCL) in women with breast implants: preliminary FDA findings and analyses. Center for Devices and Radiological Health, 2011.
23. Band PR, Gaudette LA, Hill GB, et al. The making of the Canadian cancer registry: cancer incidence in Canada and its regions, 1969 to 1988. Canadian Council of Cancer Registries, Health and Welfare Canada, Statistics Canada, Ottawa, ON, 1993.
24. Howe GR, Lindsay J,. A generalized iterative record linkage computer system for use in medical follow-up studies. Comput Biomed Res 1981; 14: 327-40.
25. Brenner DR, Tammemägi MC, Bull SB, et al. Using cancer registry data: agreement in cause-of-death data between the Ontario Cancer Registry and a longitudinal study of breast cancer patients. Chronic Dis Can 2009; 30: 16-9.
26. Ministère de la Santé et des Services Sociaux du Québec. Fichier des tumeurs du Québec. Ministère de la Santé et des Services Sociaux du Québec, 2010. Available at.
27. Matchware Technologies I. Automatch generalised record linkage system, version 4.2: user's manual. Kennebunk, Maine: MatchWare Technologies, 1998.
28. EPICURE: risk regression and data analysis software [computer program]. Seattle: Hirosoft International, 1996.
29. Breslow NE, Day NE,. Statistical methods in cancer research, vol. 2, The design and analysis of cohort studies. Lyon, France: International Agency for Research on Cancer, 1987.
30. Bernard A, Finnie R, St-Jean B,. Interprovincial mobility and earnings. Ottawa: Statistics Canada, 2008.
31. Phillips N, Coldman A,. Comparison of nonbreast cancer incidence, survival and mortality between breast screening program participants and nonparticipants. Int J Cancer 2007; 122: 197-201.
32. Kleinbaum DG, Kupper LL, Muller KE, et al. Applied regression analysis and other multivariable methods, 3rd edn. Brooks: Cole Publishing Company, 1998.
33. Kleinbaum DG, Klein M,. Survival analysis: a self leaning text, 2nd edn. Atlanta, GA: Springer, 2005.
34. Rothman KJ, Greenland S, Lash TL,. Modern epidemiology, 3rd edn. Philadelphia: Lippincott, Williams & Wilkins, 2008.
35. SAS, ed 9.2 [computer program]. Cary, NC, USA: SAS Institute, 2008.
36. Kern KA, Flannery JT, Kuehn PG,. Carcinogenic potential of silicone breast implants: a Connecticut statewide study. Plast Reconstr Surg 1997; 100: 737-47.
37. Kjoller K, Holmich LR, Fryzek JP, et al. Characteristics of women with cosmetic breast implants compared with women with other types of cosmetic surgery and populationbased controls in Denmark. Ann Plast Surg 2003; 50: 6-12.
38. Gladfelter J,. Breast augmentation 101: understanding cosmetic breast mammaplasty. Plast Surg Nurs 2007; 27: 136-45.
39. Brinton LA, Brown SL, Colton T, et al. Characteristics of a population of women with breast implants compared with women seeking other types of plastic surgery. Plast Reconstr Surg 2000; 105: 919-29.
40. Hayes H, Jr, Vandergrift J, Diner WC,. Mammography and breast implants. Plast Reconstr Surg 1988; 82: 1-8.
41. Healey CS, Ahmed S, ANECS, AOCS Management Group, O'Mara TA, Ferguson K, Lambrechts D, Garcia-Dios DA, Vergote I, Amant F, NSECG, Howarth K, Gorman M, Hodgson S, Tomlinson I, PECS, et al. Breast cancer susceptibility polymorphisms and endometrial cancer risk: a Collaborative Endometrial Cancer Study. Carcinogenis 2011; 32: 1862-6.
42. Vazquez G, Pellon A,. Polyurethane-coated silicone gel breast implants used for 18 years. Aesth Plast Surg 2007; 31: 330-6.
43. Shanmugam K, Subrahmanyam S, Tarakad SV, et al. 2,4-toluene diamines-their carcinogenicity, biodegradation, analytical techniques and an approach towards development of biosensors. Anal Sci 2001; 17: 1369-74.
44. Cunningham ML, Foley J, Maronpot RR, et al. Correlation of hepatocellular proliferation with hepatocarcinogenicity induced by the mutagenic noncarcinogen:carcinogen pair-2,6- and 2,4-diaminotoluene. Toxicol Appl Pharmacol 1991; 107: 562-7.
45. Smahel J,. Tissue reaction to breast implants coated with polyurethane. Plast Reconstr Surg 1978; 61: 80-5.
46. Slade LC, Peterson HD,. Disappearance of the polyurethane cover of the Ashley Natural Y prosthesis. Plast Reconstr Surg 1982; 70: 379-83.
47. Hester TR,. The polyurethane-covered mammary prosthesis: facts and fiction. Perspect Plast Surg 1988; 2: 135-69.
48. Szycher M, Siciliano AA,. Polyurethane- covered mammary prosthesis: a nine-year follow-up assessment. J Biomater Appl 1991; 5: 282-322.
49. Sorahan T, Pope D,. Mortality and cancer morbidity of production workers in the UK flexible polyurethane foam industry. Br J Indus Med 1993; 50: 528.
50. Hagmar L, Welinder H, Mikoczy Z,. Cancer incidence and mortality in the Swedish polyurethane foam manufacturing industry. Br J Indus Med 1993; 50: 537.